Answers are grounded in this paper and cite their sources.
Systematic review shows dexmedetomidine reduces mechanical ventilation and improves prognosis in cardiac surgery, highlighting its benefits despite risks.
Dexmedetomidine use in cardiac surgery significantly reduces all-cause and in-hospital mortality, shortens hospital length of stay, decreases ICU stay duration, and reduces mechanical ventilation requirements. However, its impact on 30-day mortality is not significant. Additionally, the drug consistently demonstrates a preventive effect on postoperative delirium across different surgical types.Clinicians must carefully weigh the benefits of this medication against the potential risk of transient hemodynamic instability.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: